Genetic variants in the LAMA5 gene in pediatric nephrotic syndrome.
Daniela A Braun,Jillian K Warejko,Shazia Ashraf,Weizhen Tan,Ankana Daga,Ronen Schneider,Tobias Hermle,Tilman Jobst-Schwan,Eugen Widmeier,Amar J Majmundar,Makiko Nakayama,David Schapiro,Jia Rao,Johanna Magdalena Schmidt,Charlotte A Hoogstraten,Hannah Hugo,Sevcan A Bakkaloglu,Jameela A Kari,Sherif El Desoky,Ghaleb Daouk,Shrikant Mane,Richard P Lifton,Shirlee Shril,Friedhelm Hildebrandt
DOI: https://doi.org/10.1093/ndt/gfy028
IF: 7.1857
2019-01-01
Nephrology Dialysis Transplantation
Abstract:Background Nephrotic syndrome (NS), a chronic kidney disease, is characterized by significant loss of protein in the urine causing hypoalbuminemia and edema. In general, approximate to 15% of childhood-onset cases do not respond to steroid therapy and are classified as steroid-resistant NS (SRNS). In approximate to 30% of cases with SRNS, a causative mutation can be detected in one of 44 monogenic SRNS genes. The gene LAMA5 encodes laminin-5, an essential component of the glomerular basement membrane. Mice with a hypomorphic mutation in the orthologous gene Lama5 develop proteinuria and hematuria. Methods To identify additional monogenic causes of NS, we performed whole exome sequencing in 300 families with pediatric NS. In consanguineous families we applied homozygosity mapping to identify genomic candidate loci for the underlying recessive mutation. Results In three families, in whom mutations in known NS genes were excluded, but in whom a recessive, monogenic cause of NS was strongly suspected based on pedigree information, we identified homozygous variants of unknown significance (VUS) in the gene LAMA5. While all affected individuals had nonsyndromic NS with an early onset of disease, their clinical outcome and response to immunosuppressive therapy differed notably. Conclusion We here identify recessive VUS in the gene LAMA5 in patients with partially treatment-responsive NS. More data will be needed to determine the impact of these VUS in disease management. However, familial occurrence of disease, data from genetic mapping and a mouse model that recapitulates the NS phenotypes suggest that these genetic variants may be inherited factors that contribute to the development of NS in pediatric patients.